Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
![Foto de Cancer Center Clínica Universidad de Navarra (CCUN)](/img/uploaded/C185D7383C9859310EFAE5D78F321270.jpg)
![Foto de University of Antwerp](/img/noimage_org.png)
University of Antwerp
Amberes, BélgicaPublicaciones en colaboración con investigadores/as de University of Antwerp (30)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
-
Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)
European Journal of Nuclear Medicine and Molecular Imaging
-
Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines
European Journal of Nuclear Medicine and Molecular Imaging
-
Treatment and outcomes in breast cancer patients: A cross section study from the EUSOMA breast centre network
European Journal of Cancer, Vol. 196
2023
-
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk
Cells, Vol. 12, Núm. 15
-
Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer
European Journal of Cancer, Vol. 189
-
Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer
Gynecologic Oncology, Vol. 170, pp. 300-308
-
Trends and variation in treatment of early breast cancer in European certified breast centres: an EUSOMA-based analysis
European Journal of Cancer, Vol. 192
-
Uncertainties and controversies in axillary management of patients with breast cancer
Cancer Treatment Reviews, Vol. 117
2022
-
Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study
Gynecologic Oncology, Vol. 166, Núm. 1, pp. 36-43
-
Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study
Nutrients, Vol. 14, Núm. 1
-
Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy
Breast, Vol. 63, pp. 123-139
-
The impact of the SARS-COV-2 pandemic on the quality of breast cancer care in EUSOMA-certified breast centres
European Journal of Cancer, Vol. 177, pp. 72-79
2021
-
Additional causal SNRPE mutations in hereditary hypotrichosis simplex
British Journal of Dermatology
-
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox
The Lancet Oncology, Vol. 22, Núm. 1, pp. e18-e28
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
In response to Haas RL et al.
Radiotherapy and Oncology
-
Local Treatment of Triple-Negative Breast Cancer
Cancer Journal (United States), Vol. 27, Núm. 1, pp. 32-40
-
Non-alcoholic fatty liver disease: A patient guideline
JHEP Reports, Vol. 3, Núm. 5
-
SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration
Brain, Vol. 144, Núm. 9, pp. 2798-2811